The mechanism of IR3G was partially proved by its structure–antioxidant relationship, anti-iNOS, anti-COX-2, and the protective activities shown against two Parkinson’s models of 6-OHDA-induced neurotoxicity in human dopaminergic neurons and locomotion deficit in zebrafish,. The gene discussed is NOS2; the disease is Parkinson disease.